Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.

A professor at the Indiana Univesity Luddy School of Informatics, Computing and Engineering has co-authored a paper ...

An international team led by Einstein Professor Cecilia Clementi in the Department of Physics at Freie Universität Berlin introduces a breakthrough in protein simulation.

The global biosimulation market is set for explosive growth, with a new forecast predicting its valuation will increase from ...

In 2025, Turbine took the first steps in opening its powerful cell simulation platform to the wider drug development community, and researchers working in the antibody-drug conjugate space are the ...

Co-authors: Roger Hancock, CEO of Recall InfoLink, and Gillian Kelleher, president and CEO of Kelleher Consultants LLC. -- OPINION -- On July 9, the FDA ...

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

This review explores how generative AI, through models like VAEs, GANs, transformers, and diffusion networks is ...

Despite ambitions to streamline regulatory review, FDA’s Elsa platform has been prone to hallucinations, prompting internal scrutiny and questions about AI reliability and governance.

Researchers have developed a program that simulates human and animal cell behavior, creating digital models of tissues and ...

In recent years, the fusion of deep tech with red and gold biotech has ushered in a new era in medicine, one defined by ...